Prof. Dr. Ahmet Dirican

Prof. Dr. Ahmet Dirican

Ana Sayfa > Doktorlar > Prof. Dr. Ahmet Dirican

Mezun Olduğu Tıp Fakültesi ve Yılı
Ege Üniversitesi Tıp Fakültesi- 2001

Uzmanlık Eğitimi Aldığı Yer ve Yılı
Ege Üniversitesi Tıp Fakültesi - 2008 İç Hastalıkları Uzmanı
İzmir Katip Çelebi Üniversitesi Tıp Fakültesi - 2013 Tıbbi Onkoloji Uzmanı
Manisa Celal Bayar Üniversitesi Tıp Fakültesi - 2015 Doçentlik Unvanı
İzmir Ekonomi Üniversitesi Tıp Fakültesi - 2022 Profesörlük Unvanı


Mesleki Deneyim
Medicalpark İzmir Hastanesi 2021- 2023
Prof.Dr. Ahmet Dirican Kanser Danışmanlık Merkezi 2023-2024

Tıbbi İlgi Alanları
İmmunoterapi
Akıllı İlaç Uygulamaları
Bireyselleşmiş Tedavi
Kanserde Genomik Profilleme Testleri
Kanserde Bütüncül Tedaviler
Tüm Kanser Tedavileri


  Bilimsel Yayınlar

A. Uluslararası hakemli dergilerde yayımlanan makaleler :

A1. Dirican A, Levent F, Alacacioglu A, Kucukzeybek Y, Varol U, Kocabas U, Senöz O, Emren SX, Demir L, Coban E, Aksun S, Sutcu R, Tarhan MO. Acute Cardiotoxic Effects of Adjuvant Trastuzumab Treatment and Its Relation to Oxidative Stress. Angiology. 2014 Feb 26. DOI: 10.1177/00033197145231

A2. Dirican A, Kucukzeybek Y, Alacacioglu A, Varol U, Aksun S, Bayoglu IV, Demir L, Coban E, Sutcu R, Tarhan MO. Impact of pre-angiogenic factors on the treatment effect of bevacizumab in patients with metastatic colorectal cancer. Med Oncol. 2014 Apr;31(4):905. doi: 10.1007/s12032-014-0905-8. Epub 2014 Mar 5.

A3. Dirican A, Kucukzeybek BB, Alacacioglu A, Kucukzeybek Y, Erten C, Varol U, Somali I, Demir L, Bayoglu IV, Yildiz Y, Akyol M, Koyuncu B, Coban E, Ulger E, Unay FC, Tarhan MO. Do the derived neutrophil to lymphocyte ratio and the neutrophil to lymphocyte ratio predict prognosis in breast cancer? Int J Clin Oncol. 2014 Feb 18. DOI 10.1007/s10147-014-0672-8 [Epub ahead of print]

A4. Dirican A, Kucukzeybek Z, Somali I, Erten C, Demir L, Can A, Payzin B, Bayoglu V,  Akyol M, Koseoglu M, Alacacioglu A, Tarhan MO, The association of  hematologic parameters on prognosis of patients with metastatic renal cell carcinoma. J BUON. 2013 Apr-Jun;18(2):413-9.

A5. Dirican A, Kucukzeybek Z, Tarhan MO, Somali I, Erten C, Demir L, Can A, Bayoglu V,  Akyol M, Ekinci N , Medeni M, Alacacioglu A. One-Day DCF Regimen in Patients with Metastatic Gastric Cancer Tumori. 2013 Mar-Apr;99(2):145-8. doi: 10.1700/1283.14183.

A6.Dirican A, Ekinci N, Avci A, Akyol M, Alacacioglu A, Kucukzeybek Y, Somali I, Erten C,  Demir L, Can A, Bayoglu IV, Koyuncu B, Tarhan MO. The Effects of Hematological Parameters and Tumor-Infiltrating Lymphocytes on Prognosis in Patients with Gastric Cancer. Cancer Biomark. 2013;13(1):11-20. doi: 10.3233/CBM-130331.

A7. Dirican A, Kucukzeybek Y, Erten C, Somali I, Demir L, Can A, Payzin KB, Bayoglu IV, Akyol M, Yildiz Y, Koeseoglu M, Alacacioglu A, Tarhan MO. Prognostic and Predictive Value of Hematologic Parameters in Patients with Metastatic Renal Cell Cancer: Second Line Sunitinib Treatment Following IFN-alpha; Preliminary Study. Asian Pacific Journal of Cancer Prevention 2013;14(3):2101-5.

A8. Dirican A, Kucukzeybek Y, Erten C, Somali I, Can A, Bayoglu IV, Akyol M Cardiac rhabdomyosarcoma of the left atrium: a case report. Contemp Oncol (Pozn). 2014;18(1),73-75

A9. Dirican A, Küçükzeybek Y, Somalι I, Erten C, Demir L, Can A, Bayoğlu IV, Ermete M, Altιnboğa AA, Tarhan MO. Cutaneous and subcutaneous metastasis from bladder carcinoma Wspolczesna Onkol 2012; 16 (5): 453–45

A10. Kucukzeybek Y, Dirican A, Erten C, Somali I, Can A, Demir L, Bayoglu IV, Akyol M, Medeni M, Tarhan MO. Second-line irinotecan after cisplatin, fluoropyrimidin and docetaxel for chemotherapy of metastatic gastric cancer. Asian Pac J Cancer Prev. 2012;13(6):2771-4

A11. S Kalemci, N Dirican, E.S Çetin, H Sözen, A.G Üner, A Yaylalı, S Aksun, V Karacam, E Ülger, R Sütcü, A Dirican., "The efficacy of minocycline against methotrexate-induced pulmonary fibrosis in mice.", European Review for Medical and Pharmacological Sciences. 2013;17(24):3334-40.

A12. Demir L, Akyol M, Bener S, Payzin KB, Erten C, Somali I, Can A, Dirican A, Bayoglu V, Kucukzeybek Y, Alacacioglu A, Calli AO, Tarhan MO. Prognostic Evaluation of Breast Cancer Patients with Evident Bone Marrow Metastasis. Breast J. 2014 Mar 27. doi: 10.1111/tbj.12264. [Epub ahead of print]

A13. Cokmert S, Demir L, Can A, Akyol M, Vedat Bayoglu I, Dirican A, Kucukzeybek Y, Erten C, Oktay Tarhan M. Capecitabine-related increased mean corpuscular volume of red blood cell may be a predictive marker of treatment response and survival in patients with metastatic colorectal cancer. J BUON. 2014 Jan-Mar;19(1):75-82.

A14. Varol U, Oktay E, Yildirim M, Surmeli ZG, Dirican A, Meydan N, Karaca B, Karabulut B, Uslu R. Tumor characteristics and metastatic sites may predict bevacizumab efficacy in the first-line treatment of metastatic colorectal cancer. Mol Clin Oncol. 2014 Jan;2(1):166-170. Epub 2013 Nov 12.

A15. Demir L, Ekinci N, Erten C, Somali I, Can A, Dirican A, Cokmert S, Bayoglu V, Akyol M, Kucukzeybek Y, Alacacioglu A, Tarhan MO. The impact of cell proliferation markers and p53 mutation status on prognosis of non-metastatic colon cancer. J Surg Oncol. 2014 Jan 24. doi: 10.1002/jso.23563. [Epub ahead of print]

A16. Cokmert S, Demir L, Akder Sari A, Kucukzeybek Y, Can A, Akyol M, Bayoglu IV, Dirican A, Erten C, Tarhan MO. Synchronous appearance of a high-grade neuroendocrine carcinoma of the ampulla vater and sigmoid colon adenocarcinoma.

Case Rep Oncol Med. 2013;2013:930359. doi: 10.1155/2013/930359. Epub 2013 Dec 3.

A17. Can A, Alacacioglu A, Kucukzeybek Y, Erten C, Cokmert S, Demir L, Dirican A, Vedat Bayoglu I, Akyol M, Aslan F, Oktay Tarhan M. The relationship of insulin resistance and metabolic syndrome with known breast cancer prognostic factors in postmenopausal breast cancer patients. J BUON. 2013 Oct-Dec;18(4):845-50.

A18. Demir L, Ekinci N, Erten C, Kucukzeybek Y, Alacacioglu A, Somali I, Can A, Dirican A, Bayoglu V, Akyol M, Cakalagaoglu F, Tarhan MO. Does immunohistochemistry provide additional prognostic data in gastrointestinal stromal tumors? Asian Pac J Cancer Prev. 2013;14(8):4751-8.

A19. Erten C, Demir L, Somali I, Alacacioglu A, Kucukzeybek Y, Akyol M, Can A, Dirican A, Bayoglu V, Tarhan MO.Cisplatin plus gemcitabine for treatment of breast cancer patients with brain metastases; a preferential option for triple negative patients? Asian Pac J Cancer Prev. 2013;14(6):3711-7.

A20. Demir L, Can A, Oztop R, Dirican A, Bayoglu V, Akyol M, Kucukzeybek Y, Erten C, Somali I, Tarhan MO. Malignant epithelioid hemangioendothelioma progressing after chemotherapy and Interferon treatment: a case presentation and a brief review of the literature.J Cancer Res Ther. 2013 Jan-Mar;9(1):125-7. doi: 10.4103/0973-1482.110386. Review.

A21. Tarhan MO, Gonel A, Kucukzeybek Y, Erten C, Cuhadar S, Yigit SC, Atay A, Somali I, Dirican A, Demir L, Koseoglu M. Prognostic Significance of Circulating Tumor Cells and Serum CA15-3 Levels in Metastatic Breast Cancer, Single Center Experience, Preliminary Results. Asian Pac J Cancer Prev. 2013;14(3):1725-9.

A22. Alacacioglu A, Tarhan O, Alacacioglu I, Dirican A, Yilmaz U. Depression and anxiety in cancer patients and their relatives. J BUON. 2013 Jul-Sep;18(3):767-74.

A23. Akyol M, Demir L, Dirican A, Ekinci E, Can A, Bayoglu V, Alacacioglu A, Kucukzeybek Y, Cokmert S, Erten C, Cakalagaoglu F, Tarhan MO. Letter to Editor Skin and maxillary sinus involvement of colon cancer. Contemp Oncol (Pozn). 2014;18(1),70-72.

A24. Demir L, Erten C, Somali I, Can A, Dirican A, Bayoglu V, Kucukzeybek Y, Altinboga AA, Ermete M, Oztop RM, Tarhan MO. Metastases of renal cell carcinoma to the larynx and thyroid: Two case reports on metastasis developing years after nephrectomy Can Urol Assoc J 2012;6(5):E209-E212. doi.org/10.5489/cuaj.11255

A25.Tarhan MO, Demir L, Somali I, Yigit S, Erten C, Alacacioglu A, Ellidokuz H, Seseogullari O, Kucukzeybek Y, Can A, Dirican A, Bayoglu V, Akyol M. The clinicopathological evaluation of the breast cancer patientswith brain metastases: predictors of survival . Clin Exp Metastasis . 2013 Feb;30(2):201-13. doi:10.1007/s10585-012-9528-7. Epub 2012 Aug 23

A26. Yigit S, Demir L, Tarhan MO, Cabuk FK, Ellidokuz H, Erten C, Somali I, Dirican A, Cakalagaoglu F. The clinicopathological significance of Bax and Bcl-2 protein expression with tumor infiltrating lymphocytes in ovarian carcinoma.Neoplasma. 2012;59(5):475-85.

A27. Demir L, Can A, Dirican A, Bayoğlu V, Rezanko TA, Akyol M, Kucukzeybek Y, Erten C, Tarhan MO. Malignant fibrous histiocytoma of the spermatic cord in a patient with polycystic kidney disease; review of the literature. Clin Genitourin Cancer.  2012Dec;10(4):280-3. doi: 10.1016/j.clgc.2012.03.003. Epub 2012 Apr 6.    

A28. Demir L, Erten C, Yigit SC, Can A, Dirican A, Bayoglu V, Kucukzeybek Y, Somali I, Tarhan MO. Intramammary lymph node metastasisin a patient with ovarian carcinoma and a brief review of the literature. współczesna onkologia/contemporary oncology 2012; 16 (2): 108–110

A29. Cuhadar S, Atay A, Koseoglu M, Dirican A, Hur A.Stability studies of common biochemical analytes in serum separator tubes with or without gel barrier subjected to various storage conditions.Biochem Med (Zagreb). 2012;22(2):202-14.

A30.Cuhadar S, Koseoglu M, Atay A, Dirican A.The effect of storage time and freeze-thaw cycles on the stability of serum samples. Biochem Med (Zagreb). 2013;23(1):70-7.

A31. Demir L, Somali I, Oktay Tarhan M, Erten C, Ellidokuz H, Can A, Dirican A, Vedat Bayoglu I. The toxicity and efficacy of Nordic-FLOX regimen as adjuvant treatment of stage III colon cancer. J BUON. 2011 Oct-Dec;16(4):682-8.

A32. Demir L, Yigit S, Ellidokuz H, Erten C, Somali I, Kucukzeybek Y, Alacacioglu A, Cokmert S, Can A, Akyol M, Dirican A, Bayoglu V, Sari AA, Tarhan MO. Predictive and prognostic factors in locally advanced breast cancer: effect of intratumoral FOXP3+ Tregs. Clin Exp Metastasis. 2013 Jul 9. [Epub ahead of print]

A33. Ece H, Cigdem E, Yuksel K, Ahmet D, Hakan E, Oktay TM. The use of oral antidiabetic drugs (metformin and pioglitazone) in diabetic patients with breast cancer: How does It effect on serum HIF-1 alpha and 8OHdG levels ? Asian Pac J Cancer Prev. 2012;13(10):5143-8.

A34. Dirican A, Kucukzeybek Y, Somali I, Erten C, Demir L, Can A, Bayoglu IV, Yigit SC, Unay FC, Yetimalar MH, Tarhan MO. Micro-metastases into the uterine leiomyoma from invasive ductal breast cancer under adjuvant tamoxifen therapy: Case report. Eur J Gynaecol Oncol. 2012;33(6):652-5.

A35. Dirican A, Atmaca H, Bozkurt E, Erten C, Karaca B, Uslu R. Novel combination of docetaxel and thymoquinone induces synergistic cytotoxicity and apoptosis in DU-145 human prostate cancer cells by modulating PI3K-AKT pathway. Clin Transl Oncol. 2014 Jul 25. [Epub ahead of print]. DOI 10.1007/s12094-014-1206-6.

A36. Dirican A, Varol U, Kucukzeybek Y, Alacacioglu A, Erten C, Somali I, Can A, Demir L, Bayoglu IV, Akyol M, Yildiz Y, Koyuncu B, Coban E, Tarhan MO Treatment of metastatic colorectal cancer with or without bevacizumab: can the neutrophil/lymphocyte ratio predict the efficiency of bevacizumab? Asian Pac J Cancer Prev. 2014;15(12):4781-6.

A37. Dirican A, Levent F, Alacacioglu A, Kucukzeybek Y, Varol U, Kocabas U, Senöz O, Emre SV, Demir L, Coban E, Aksun S, Sutcu R, Tarhan MO. Acute Cardiotoxic Effects of Adjuvant Trastuzumab Treatment and its Relation to Oxidative Stress. Angiology. 2014 Jun 5. DOI: 10.1177/0003319714536602. [Epub ahead of print]

A38. Varol U, Dirican A, Yildiz I, Oktay E, Degirmenci M, Alacacioglu A, Barutca S, Karabulut B, Uslu R.First-line mono-chemotherapy in frail elderly patients with metastatic colorectal cancer. Asian Pac J Cancer Prev. 2014;15(7):3157-61.

A39. Alacacioglu A, Ulger E, Varol U, Yavuzsen T, Akyol M, Yildiz Y, Yildiz I, Bayoglu V, Dirican A, Demir L, Salman T, Kucukzeybek Y, Alacacioglu I, Can H, Tarhan MO. Sexual satisfaction, anxiety, depression and quality of life in testicular cancer survivors. Med Oncol. 2014 Jul;31(7):43. doi: 10.1007/s12032-014-0043-3. Epub 2014 Jun 10.

A40. Akyol M, Varol U, Yildiz I, Bayoglu IV, Yildiz Y, Demir L, Dirican A, Can A, Cokmert S, Oztop MT, Alacacioglu A, Kucukzeybek Y, Tarhan MO.Isolated liver metastasis of sacrococcygeal chordoma: case report and review of the literature. Case Rep Oncol Med. 2014;2014:826584. doi: 10.1155/2014/826584. Epub 2014 Jun 11.

A41. Kucukzeybek BB, Calli AO, Kucukzeybek Y, Bener S, Dere Y, Dirican A, Payzin KB, Ozdemirkiran F, Tarhan MO. The prognostic significance of bone marrow metastases: Evaluation of 58 cases. Indian J Pathol Microbiol 2014;57:396-9

A42. Bayoglu IV, Varol U, Yildiz I, Muslu U, Alacacioglu A, Kucukzeybek Y, Akyol M, Demir L, Dirican A, Cokmert S, Yildiz Y, Karabulut B, Uslu R, Tarhan MO. Second-line capecitabine and oxaliplatin combination for gemcitabine-resistant advanced pancreatic cancer. Asian Pac J Cancer Prev. 2014;15(17):7119-23.

A43. M Akyol, Leyla Demir, A Alacacioglu, H Ellidiokuz, Y Kucukzeybekl, Y Yildiz, V Bayoglu, I Yildiz, T Salman, U Varol, B Kucukzeybek, Lütfiye Demir, A Dirican, R Sutcu, O Tarhan The effects of adjuvant endocrine treatment on the serum leptin, adiponectin and body composition in patients with breast cancer [Izmir Oncology Group (IZOG) Study]. Chemotherapy. 2016; 61 (2): 57-64. doi: 10.1159 / 000440944.

A44. Oktay E, Yalcin GD, Ekmekci S, Kahraman DS, Yalcin A, Degirmenci M, Dirican A, Altin Z, Ozdemir O, Surmeli Z, Diniz G, Ayhan S, Bulut G, Erdogan A, Uslu R.  Programmed cell death ligand-1 expression in gastroenteropancreatic neuroendocrine tumors. J BUON. 2019. PMID: 31128036

A45. Dirican A, Sahin O, Taslı F, Sogut E, Kucukzeybek Y, Alacacioglu A, Gunes M, Saglam G, Coban E, Tarhan MO, Demirci B. Thymoquinone enhances cisplatin-induced neprotoxicity in high dose. Journal of Oncological Science. 2016; (1): 17-24

A46. Dirican A, Ekinci F, Erdoğan AE, Öztürk GG. Inflammatory prognostic index score as a new parameter predicting overall survival in renal cell carcinoma. J Surg Med. 2021;5(2):163-167.  DOI: 10.28982/josam.850739

A47. Ekinci F, Sarı D, Celik C, Dirican A, Erdogan AP, Goksel G. Can Albumin Bilirubin Ratio and Inflammatory Prognostic Index Be A New Marker Determining Survival in Metastatic Pancreatic Cancer? G. J. O. Issue 36, 2021

A48. Erdogan AP, Ekinci F, Karabas A, Balcık OY, Barutca S, Dirican A.Could the Inflammatory Prognostic Index Predict the Efficacy of Regorafenib in Patients with Metastatic Colorectal Cancer? Journal of Gastrointestinal Cancer. Published online 21 April 2021. https://doi.org/10.1007/s12029-021-00642-w

A49. Ekinci F, Dirican A, Altınısık M, Ovalı GY, Erdogan AP, Goksel G. Retinal Detachment Due to Choroidal Metastasis in a Patient with Lung Cancer. Tepecik Eğit. ve Araşt. Hast. Dergisi 2021;31(2):269-71 doi:10.5222/terh.2021.08769

A50. Almacan B, Gokcen S, Kılınc M, Ekinci F, Dirican A, Ozturk G, Erdogan AP. The effects of enteral and parenteral nutrition on clinical outcomes in cancer inpatients receiving palliative care. D J Med Sci 2020;6(2):49-52

A51. Tural D, Ölmez ÖF, Sümbül AT, Artaç M, Özhan N, Akar E, Çakar B, Köstek O, Ekenel M, Erman M, Coşkun HŞ, Selçukbiricik F, Keskin Ö, Türköz FP, Oruç K, Bayram S, Yılmaz U, Bilgetekin İ, Yıldız B, Şendur MAN, Paksoy N, Dirican A, Erdem D, Selam M, Tanrıverdi Ö, Paydaş S, Urakçı Z, Atağ E, Güncan S, Ürün Y, Alkan A, Kaya AO, Özyükseler DT, Taşkaynatan H, Yıldırım M, Sönmez M, Başoğlu T, Gündüz Ş, Kılıçkap S.Atezolizumab in Patients with Metastatic Urothelial Carcinoma Who Have Progressed After First-line Chemotherapy: Results of Real-life Experiences.

Eur Urol Focus. 2021 Sep;7(5):1061-1066. doi: 10.1016/j.euf.2020.09.010. Epub 2020 Sep 30.PMID: 33008789 

A52. Yolcu A, Dirican A, Ozturk G, Cetin B, Aydogdu I. A rare parasitic infection: visceral leishmaniasis case after gastric cancer treatment. memo (2018) 11:345–347 https://doi.org/10.1007/s12254-018-0437-6

A53. Vinorelbine Induced Serpentine Supravenous Hyperpigmentation. Yetut A, Tas S, Ekinci F, Celik C, Erdogan A, Dirican A. J Oncol Sci. 2022;8(1):54-6. DOI: 10.37047/jos.2022-88125

A54- Tural D, Ölmez ÖF, Sümbül AT, Artaç M, Özhan N, Akar E, Çakar B, Köstek O, Ekenel M, Erman M, Coşkun HŞ, Selçukbiricik F, Keskin Ö, Türköz FP, Oruç K, Bayram S, Yılmaz U, Bilgetekin İ, Yıldız B, Şendur MAN, Paksoy N, Dirican A, Erdem D, Selam M, Tanrıverdi Ö, Paydaş S, Urakçı Z, Atağ E, Güncan S, Ürün Y, Alkan A, Kaya AO, Özyükseler DT, Taşkaynatan H, Yıldırım M, Sönmez M, Başoğlu T, Gündüz Ş, Kılıçkap S.Prognostic factors in patients with metastatic urothelial carcinoma who have treated with Atezolizumab Int J Clin Oncol 2021 Aug;26(8):1506-1513. doi: 10.1007/s10147-021-01936-6. Epub 2021 May 23.

A55-Association of intra-tumoral tumour-infiltrating lymphocytes and neutrophil-to-lymphocyte ratio is an independent prognostic factor in non-small cell lung cancer. Clin Respir J. 2017 Nov;11(6):789-796. doi: 10.1111/crj.12417. Dirican N, Karakaya YA, Gunes S, Daloglu FT, Dirican A


B. Yazılan kitaplar veya kitaplarda bölümler

Yapılan Uluslararası Kitap Bölüm Çevirileri

1-Devita, Hellman, and Rosenberg's Cancer: Principles and Practice of Oncology; 10. baskı,

2018;

Bölüm 47 Mide Kanserinde Genetik Testler ;

Bölüm 62 Böbrek Kanserinin Moleküler Biyolojisi

2-Oxford Handbook of Oncology .Jim Cassidy, Donald Bissett , Roy A. J. Spence OBE ,

Miranda Payne, and Gareth Morris-Stiff. 4. baskı, 2015,

Bölüm: Genitoüriner Kanserler

ULUSAL KİTAP BÖLÜMÜ

1-Türkiye Klinikleri Tıbbi Onkoloji Nadir Tümörler  2020, Nadir Renal Kanserler Bölümü, 1.

Baskı. Ankara: Türkiye Klinikleri; 2020. p.104-9. 

C. Ulusal hakemli dergilerde yayımlanan makaleler :

C1-Demir L, Rezanko T, Akyol M, Bayoglu V, Dirican A, Can A, Cokmert S, Kucukzeybek Y, Alacacioglu A, Erten C, Somali I, Tarhan MO. Malıgnant hemangıoperıcytoma; report of two cases wıth dıfferent behavıour and revıew of lıterature. Türkiye Klinikleri Journal of Medical Research-Case Reports.2013;21(1):18-23

C2-Dirican A, Kucukzeybek Z, Tarhan MO, Somali I, Erten C, Demir L, Can A, Bayoglu V,  Akyol M, Ekinci N, Medeni M, Alacacioglu A. Induction or Adjuvant Docetaxel/Cisplatin Chemotherapy in Advanced Non-Metastatic Nasopharyngeal Cancer.Kocatepe Tıp Dergisi. 2014;15(1):92-8

C3-Ekinci F, Erdogan AP, Dirican A, Göksel G. Metastatik Renal Hücreli Karsinom Tanılı Hastalarımızda Nötrofil Lenfosit Oranının Prognoz Üzerine Etkisi.Abant Med J 2021;10 (1):136-141

C4- Erdogan AP, Ekinci F, Dirican A, Celik C, Eniseler EB, Almacan B, Goksel G.The Effect of Neutrophil Lymphocyte Ratio on Prognosis of Ovarian Cancer. Türk Jinekolojik Onkoloji Dergisi 2020-1, Sayfa 13-16

C5- Kolkıran N, Ekinci F, Erdogan AP, Goktan C, Goksel G, Dirican A. High Grade Neuroendocrine Carcinoma Diagnosed by Superior Vena Cava Syndrome: Case Report. CBU-SBED, 2020, 7(2): 243-246

C6- Erdogan AP, Ekinci F, Ozveren A, Celik C, Ates GA, Akay S, Dirican A. Evaluation of Clinical and Prognostic Features in Hepatocellular Carcinoma: A Single Center Experience.CBU-SBED, 2021, 8(3): 410-413

C7- Skin Toxicity caused by Cranial Radiotherapy in Lapatinib - Capecitabine Treatment: A Case Report. Eniseler EB, Ekinci F, Erdoğan AP, Dirican A, Goksel G. Türk Jinekolojik Onkoloji Dergisi 2020-1, Sayfa 21-24

C8- Dirican A, Dirican N, Ölmezoğulu A. İleri Evre Küçük Hücreli Dışı Akciğer Kanserinde Hedef Driver Mutasyonların Tespitinde Likit Biyopsi Doku Biyosinin Yerini Alabilir mi? CBÜ SBED, 2016, 3(2):165-168

Prof. Dr. Ahmet Dirican Medicana Sağlık Grubu'na ait MEDICANA INTERNATIONAL İZMİR hastanesinde çalışmaktadır.

Prof. Dr. Ahmet Dirican hekimimizin Medikal Onkoloji alanında uzmanlığı bulunmaktadır.

UZMANLARIMIZA
SORUN

MEDICANA Sağlık Grubu hekimleriyle sağlığınızla ilgili sorularınızı, rapor ve sonuçlarınızı (laboratuar, görüntüleme, vb.) paylaşabilir, tüm bölümlerle ilgili ikinci görüş alabilirsiniz.. Alanında uzman hekim kadromuz paylaşacağınız bilgileri değerlendirip en kısa sürede sorularınızı yanıtlayacaktır.
Acil durumlar için 0850 460 6334 nolu çağrı merkezimizden destek alabilirsiniz

Dosya boyutu maksimum 20 mb olmalıdır.

Kişisel Verilerin Korunması Kanunu uyarınca ilgili Bilgilendirme’yi okudum. Kişisel verilerimin belirtilen kapsamda işlenmesini ve sağlık hizmet sunumu amacıyla tarafımla iletişime geçilmesini kabul ediyorum.

İlerlemek istiyorsanız lütfen bu kutuyu işaretleyin.

EN FAZLA GÖRÜNTÜLENENLER

E-RANDEVU